scholarly journals High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening

2018 ◽  
Vol 9 (12) ◽  
pp. 3192-3199 ◽  
Author(s):  
Shanshan Qin ◽  
Mengmeng Meng ◽  
Dehua Yang ◽  
Wenwen Bai ◽  
Yan Lu ◽  
...  

High-throughput identification of GPCR modulators through affinity MS screening.

2007 ◽  
Vol 79 (6) ◽  
pp. 2189-2198 ◽  
Author(s):  
Isabel D. Alves ◽  
Emmanuelle Sachon ◽  
Gerard Bolbach ◽  
Lynda Millstine ◽  
Solange Lavielle ◽  
...  

Author(s):  
Daniel L. Bassoni ◽  
Qumber Jafri ◽  
Sunitha Sastry ◽  
Mahesh Mathrubutham ◽  
Tom S. Wehrman

2019 ◽  
Vol 91 (13) ◽  
pp. 8162-8169 ◽  
Author(s):  
Yan Lu ◽  
Shanshan Qin ◽  
Bingjie Zhang ◽  
Antao Dai ◽  
Xiaoqing Cai ◽  
...  

2019 ◽  
Vol 24 (9) ◽  
pp. 915-927
Author(s):  
P. Heine ◽  
G. Witt ◽  
A. Gilardi ◽  
P. Gribbon ◽  
L. Kummer ◽  
...  

The development of cell-free high-throughput (HT) methods to screen and select novel lead compounds remains one of the key challenges in G protein-coupled receptor (GPCR) drug discovery. Mutational approaches have allowed the stabilization of GPCRs in a purified and ligand-free state. The increased intramolecular stability overcomes two major drawbacks for usage in in vitro screening, the low receptor density on cells and the low stability in micelles. Here, an HT fluorescence polarization (FP) assay for the neurotensin receptor type 1 (NTS1) was developed. The assay operates in a 384-well format and is tolerant to DMSO. From a library screen of 1272 compounds, 12 (~1%) were identified as primary hits. These compounds were validated in orthogonal assay formats using surface plasmon resonance (SPR), which confirmed binding of seven compounds (0.6%). One of these compounds showed a clear preference for the orthosteric binding pocket with submicromolar affinity. A second compound revealed binding at a nonorthosteric binding region and showed specific biological activity on NTS1-expressing cells. A search of analogs led to further enhancement of affinity, but at the expense of activity. The identification of GPCR ligands in a cell-free assay should allow the expansion of GPCR pharmaceuticals with antagonistic or agonistic activity.


2000 ◽  
Vol 5 (4) ◽  
pp. 239-247 ◽  
Author(s):  
Anthony C. Chiulli ◽  
Karen Trompeter ◽  
Michelle Palmer

The second messenger 3′, 5′-cyclic AMP (cAMP) is a highly regulated molecule that is governed by G protein-coupled receptor activation and other cellular processes. Measurement of cAMP levels in cells is widely used as an indicator of receptor function in drug discovery applications. We have developed a nonradioactive ELISA for the accurate quantitation of cAMP levels produced in cell-based assays. This novel competitive assay utilizes chemiluminescent detection that affords both a sensitivity and a dynamic assay range that have not been previously reported with any other assay methodologies. The assay has been automated in 96- and 384-well formats, providing assay data that are equivalent to, if not better than, data generated by hand. This report demonstrates the application of this novel assay technology to the functional analysis of a specific G protein-coupled receptor, neuropeptide receptor Y1, on SK-N-MC cells. Our data indicate the feasibility of utilizing this assay methodology for monitoring cAMP levels in a wide range of functional cell-based assays for high throughput screening.


Sign in / Sign up

Export Citation Format

Share Document